Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review

被引:7
|
作者
Okeah, Bernard O. [1 ]
Ridyard, Colin H. [2 ]
机构
[1] Bangor Univ, Sch Healthcare Sci, Bangor LL57 2EF, Gwynedd, Wales
[2] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Normal Site, Bangor LL57 2PZ, Gwynedd, Wales
关键词
HUMAN-PAPILLOMAVIRUS VACCINATION; HEALTH-CARE DECISIONS; CERVICAL-CANCER; ECONOMIC EVALUATIONS; VIRUS VACCINE; PREVENTION; THRESHOLDS; GUIDELINES; PREPARE; RISK;
D O I
10.1007/s40258-020-00576-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Cervical cancer ranks fourth amongst the commonest malignancies worldwide and the second most prevalent cancer afflicting women in low-to-middle income countries (LMICs), hence, of great public health importance. LMICs are the most affected regions as evidenced by their high prevalence of the disease. Mortality associated with cervical neoplasms is preventable through the implementation of recommended preventive approaches. Aims This review aimed to appraise evidence on the cost effectiveness of cervical cancer prevention interventions in LMICs involving cervical screening and human papilloma virus (HPV) vaccination programmes. Methods A search of CINAHL, MEDLINE, PubMed, and Web of Science was elicited and studies published between 1st January 2008 and 31st December 2018 were retrieved. Two authors independently undertook the screening, review, selection of studies, and data extraction with disagreements being resolved through discussion and consensus. Results Twelve studies were selected. The cost-effectiveness outcomes of HPV vaccination and screening interventions are dependent on age, screening method used, intervention coverage, and the number of doses or visits required for vaccination and screening, respectively. A combination of visual inspection with acetic acid (VIA) screening and HPV vaccination appears to be the most cost-effective approach in reducing the lifetime risk for HPV-linked cervical neoplasms. Similarly, vaccination as a stand-alone intervention is potentially cost effective provided the coverage is maintained between 70 and 100%. Conclusions HPV vaccination and screening interventions may be cost effective in LMICs and potentially reduce the lifetime risk, economic burden, and associated mortality. However, it is important to consider the factors that influence the cost effectiveness of cervical cancer prevention interventions for better outcomes to be realised.
引用
收藏
页码:641 / 654
页数:14
相关论文
共 50 条
  • [21] Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
    Ozawa, Sachiko
    Mirelman, Andrew
    Stack, Meghan L.
    Walker, Damian G.
    Levine, Orin S.
    VACCINE, 2012, 31 (01) : 96 - 108
  • [22] Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022
    Gharpure, Radhika
    Chard, Anna N.
    Escobar, Maria Cabrera
    Zhou, Weigong
    Valleau, Molly M.
    Yau, Tat S.
    Bresee, Joseph S.
    Azziz-Baumgartner, Eduardo
    Pallas, Sarah W.
    Lafond, Kathryn E.
    PLOS MEDICINE, 2024, 21 (01)
  • [23] Systematic review of the cost-effectiveness of the vaccination against HPV in Brazil
    Fonseca, Allex Jardim
    de Lima Ferreira, Luiz Carlos
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (12) : 3484 - 3490
  • [24] Cost-effectiveness of extending the HPV vaccination to boys: a systematic review
    Linertova, Renata
    Guirado-Fuentes, Carmen
    Mar Medina, Javier
    Imaz-Iglesia, Inaki
    Rodriguez-Rodriguez, Leticia
    Carmona-Rodriguez, Montserrat
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2021, 75 (09) : 910 - 916
  • [25] The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
    Kostova, Deliana
    Spencer, Garrison
    Moran, Andrew E.
    Cobb, Laura K.
    Husain, Muhammad Jami
    Datta, Biplab Kumar
    Matsushita, Kunihiro
    Nugent, Rachel
    BMJ GLOBAL HEALTH, 2020, 5 (09):
  • [26] Assessing Cost-Effectiveness of HPV Vaccines with Decision Analytic Models: What Are the Distinct Challenges of Low And Middle Income Countries? A Protocol for a Systematic Review
    Ekwunife, Obinna I.
    Grote, Andreas Gerber
    Mosch, Christoph
    O'Mahony, James F.
    Lhachimi, Stefan K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 478 - 478
  • [27] Cost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries
    Siedner, Mark J.
    Alba, Christopher
    Fitzmaurice, Kieran P.
    Gilbert, Rebecca F.
    Scott, Justine A.
    Shebl, Fatma M.
    Ciaranello, Andrea
    Reddy, Krishna P.
    Freedberg, Kenneth A.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11): : 1887 - 1896
  • [28] Cardiac rehabilitation in low- and middle-income countries: a review on cost and cost-effectiveness
    Oldridge, Neil B.
    Pakosh, Maureen T.
    Thomas, Randal J.
    INTERNATIONAL HEALTH, 2016, 8 (02): : 77 - 82
  • [29] Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
    Horton, Susan
    Gelband, Hellen
    Jamison, Dean
    Levin, Carol
    Nugent, Rachel
    Watkins, David
    PLOS ONE, 2017, 12 (08):
  • [30] Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
    Linde, Mattias
    Steiner, Timothy J.
    Chisholm, Dan
    JOURNAL OF HEADACHE AND PAIN, 2015, 16